June 2026– date –
-
ASCO 2026 Highlights CAR-T Cell Therapy Evolution in Multiple Myeloma: Focus on Rapid Manufacturing, Dual-Targeting, and Lentiviral Approaches
YouTube (OncUpdates) USA Overview A YouTube video featuring Dr. Hamza Hashmi discussed the latest advancements in CAR-T therapy for multiple myeloma at ASCO 2026. CAR-T therapy has evolved from a last-resort treatment to a viable option ... -
CDMO Signal Ranks Lentiviral Vector (LVV) CDMOs: GMP Standards and Robust Assays Key for Selection
CDMO Signal USA Overview CDMO Signal published its ranking of Lentiviral Vector (LVV) CDMOs based on Signal Score. LVVs are critical in ex vivo gene therapies for engineering CAR-T cells and modifying hematopoietic stem cells, necessitat... -
PMC Reports Multi-Component 3D Bioprinted Platform with Sacrificial Matrix and Collagen-Based Bioinks Developed for Skeletal Muscle Tissue Engineering
PMC (Published in Pharmaceutics) USA Overview A study published in PMC (Pharmaceutics) describes a multi-component 3D bioprinted platform for skeletal muscle tissue engineering. This system integrates a PCL support for mechanical stabili... -
Frontiers Reports VR-Based Bioreactor Developed for Biomanufacturing and Environmental Engineering Labs: Enhancing Student Education and Access to High-Cost Equipment
Frontiers in Education Switzerland Overview A study published in Frontiers in Education describes the development of a virtual reality (VR)-based bioreactor for biomanufacturing and environmental engineering labs. Modeled after a detaile... -
Qihan Biotech Receives FDA RMAT and Breakthrough Therapy Designations for Universal Dual-Target CAR-T Therapy, Supported by PackGene Biotech’s CDMO Expertise
PackGene Biotech China Overview Qihan Biotech announced that its universal dual-target CAR-T therapy received both Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy designations from the U.S. FDA. PackGene Biotech, a... -
Lonza Presents Optimization Strategies to Address Purity and Potency Challenges in In Vivo Lentiviral Vector Development for Cell and Gene Therapies
Biocompare Switzerland Overview Lonza outlined optimization strategies for lentiviral vector (LVV) development for in vivo delivery of cell and gene therapies. Key challenges in LVV development include achieving purity, complexity of val... -
YouTube Video Discusses Cultivated Meat’s Civic Implications: Centralized Production and Patent Ownership’s Impact on Food Security Highlighted
YouTube (NextGen Civic News) USA Overview A NextGen Civic News YouTube video discussed the civic implications of cultivated meat. While Upside Foods and Good Meat have received regulatory approval for cultivated meat in the U.S., concern... -
Mosa Meat’s Mark Post Files for EU Cultivated Meat Approval, Citing Cost Reduction and Plant-Based Media as Key Challenges
Food Navigator Europe Overview Mosa Meat's co-founder Mark Post announced the company has filed for regulatory approval of its cultivated meat products in the European Union, following previous approvals in Singapore, Israel, and the Uni... -
ORF Genetics Dramatically Cuts Cultivated Meat Production Costs by Producing Growth Factors Using Barley
Farmtario Canada Overview Barley is reported to play a crucial role in cultivated meat production without animal rearing. ORF Genetics developed an innovative technology to produce animal growth factors, essential for cultivated meat cel... -
Cytiva CEO Pierre-Alain Ruffieux Emphasizes Standardization and Automation for Scaling Cell and Gene Therapy Manufacturing Ahead of BIO 2026
BioPharm International USA Overview Ahead of BIO International Convention 2026, Cytiva CEO Pierre-Alain Ruffieux discussed scaling cell and gene therapy (CGT) manufacturing to expand global access. He emphasized standardization and autom...
